Biotech

All Articles

Cassava pays for $40M over allegedly confusing Alzheimer's update

.Cassava Sciences has actually consented to pay $40 million to fix an inspection in to cases it made...

Merck bags alternatives on Evaxion's AI-designed vaccination prospects

.Merck &amp Co. has actually gotten options on pair of Evaxion Biotech vaccine applicants, spending ...

Enanta's RSV antiviral crushes virus-like tons in challenge research study

.Enanta Pharmaceuticals has actually connected its own respiratory system syncytial virus (RSV) anti...

Biogen canisters SAGE-324 partnership after crucial trembling fail

.Biogen has administered the last rites to its cooperation with Sage Rehabs on SAGE-324, scrapping t...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel acquistion credit ratings

.On the very same time that some Parkinson's disease drugs are being cast doubt on, AbbVie has actua...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arc Endeavor Partners is ...

Orion to use Aitia's 'digital identical twins' to discover brand-new cancer cells medications

.Finnish biotech Orion has snooped potential in Aitia's "electronic identical twin" technician to de...

Windtree's shock med brings up high blood pressure in most recent phase 2 gain

.While Windtree Therapies has actually battled to grow the economic roots needed to endure, a period...

2 cancer biotechs combine, producing international footprint

.OncoC4 is taking AcroImmune-- and also its own internal clinical manufacturing capacities-- under i...

Amgen reports initial stage 3 gain for $400M chronic eczema drug

.Amgen has actually shared (PDF) the first stage 3 data on its own $400 thousand eczema drug, connec...